Schedule 13G ownership disclosure

QUINCE THERAPEUTICS INC

Security class unavailable · CUSIP: 22053A107

Event date: 2021-02-26

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,170,731
Percent of class
10.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-21-000132
Form type
SC 13G/A
Filer
Capital World Investors
CIK
CIK 1422849
Filed
Mar 10, 2021
Reporting period
Feb 26, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub